A detailed history of Korea Investment Corp transactions in Pfizer Inc stock. As of the latest transaction made, Korea Investment Corp holds 3,810,931 shares of PFE stock, worth $102 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
3,810,931
Previous 3,768,348 1.13%
Holding current value
$102 Million
Previous $105 Million 4.6%
% of portfolio
0.27%
Previous 0.27%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $1.18 Million - $1.34 Million
42,583 Added 1.13%
3,810,931 $110 Million
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $3.42 Million - $4.01 Million
135,496 Added 3.73%
3,768,348 $105 Million
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $8.85 Million - $10.2 Million
-341,798 Reduced 8.6%
3,632,852 $101 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $17.4 Million - $22.7 Million
667,547 Added 20.19%
3,974,650 $114 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $34.2 Million - $40 Million
-1,065,852 Reduced 24.37%
3,307,103 $110 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $14.2 Million - $16.4 Million
-392,289 Reduced 8.23%
4,372,955 $160 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $22.7 Million - $29.6 Million
-577,120 Reduced 10.8%
4,765,244 $194 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $15.1 Million - $19.7 Million
361,034 Added 7.25%
5,342,364 $274 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $3.44 Million - $4.2 Million
78,601 Added 1.6%
4,981,330 $218 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $19.6 Million - $23.2 Million
421,036 Added 9.39%
4,902,729 $257 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $3.18 Million - $3.93 Million
-69,411 Reduced 1.53%
4,481,693 $232 Million
Q4 2021

Feb 09, 2022

BUY
$41.32 - $61.25 $62.7 Million - $93 Million
1,518,117 Added 50.05%
4,551,104 $269 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $4.69 Million - $6.03 Million
119,523 Added 4.1%
3,032,987 $130 Million
Q2 2021

Aug 12, 2021

SELL
$35.91 - $40.68 $2.23 Million - $2.53 Million
-62,155 Reduced 2.09%
2,913,464 $114 Million
Q1 2021

May 13, 2021

BUY
$33.49 - $37.77 $15.8 Million - $17.8 Million
470,694 Added 18.79%
2,975,619 $108 Million
Q4 2020

Feb 10, 2021

BUY
$33.47 - $42.56 $9.12 Million - $11.6 Million
272,529 Added 12.21%
2,504,925 $92.2 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $28.6 Million - $33.6 Million
-901,800 Reduced 28.77%
2,232,396 $81.9 Million
Q2 2020

Aug 12, 2020

SELL
$30.12 - $36.54 $41.4 Million - $50.3 Million
-1,375,300 Reduced 30.5%
3,134,196 $102 Million
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $6.1 Million - $8.71 Million
-225,500 Reduced 4.76%
4,509,496 $147 Million
Q4 2019

Feb 11, 2020

BUY
$32.92 - $37.36 $12 Million - $13.6 Million
365,100 Added 8.35%
4,734,996 $186 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $464,607 - $602,459
14,300 Added 0.33%
4,369,896 $157 Million
Q2 2019

Aug 12, 2019

SELL
$36.98 - $41.52 $1.72 Million - $1.93 Million
-46,400 Reduced 1.05%
4,355,596 $189 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $5.51 Million - $6.06 Million
147,037 Added 3.46%
4,401,996 $187 Million
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $3.02 Million - $3.44 Million
-78,400 Reduced 1.81%
4,254,959 $186 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $12.9 Million - $15.7 Million
-375,560 Reduced 7.98%
4,333,359 $191 Million
Q2 2018

Aug 13, 2018

BUY
$32.98 - $35.16 $2.97 Million - $3.17 Million
90,200 Added 1.95%
4,708,919 $0
Q1 2018

May 09, 2018

SELL
$31.91 - $37.02 $1.25 Million - $1.45 Million
-39,085 Reduced 0.84%
4,618,719 $164 Million
Q4 2017

Feb 12, 2018

BUY
$33.26 - $35.29 $18.4 Million - $19.5 Million
552,200 Added 13.45%
4,657,804 $169 Million
Q3 2017

Oct 25, 2017

BUY
$31.0 - $34.15 $127 Million - $140 Million
4,105,604
4,105,604 $147 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Korea Investment Corp Portfolio

Follow Korea Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.